FibroGen (FGEN) Earnings Date & Reports

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

FGEN is expected to report earnings to fall 155.56% to -10 cents per share on May 12

Q1'25

Est.

$-0.10

Q4'24

Beat

by $0.35

Q3'24

Beat

by $0.14

Q2'24

Beat

by $0.16

Q1'24

Beat

by $0.08

The last earnings report on March 17 showed earnings per share of 18 cents, beating the estimate of -17 cents. With 506.90K shares outstanding, the current market capitalization sits at 30.23M.

View a ticker or compare two or three

Compare

FGEN